Showing results (161-170 of 651) with videos related to

Sort By:
Pageof 66
Clinical Proteomics|December 3, 2010
Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic PatientsAnne Julie Overgaard, Tine E Thingholm, Martin R Larsen, et al.
Metabolites|September 22, 2019
Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic PatientsLinda Ahonen, Sirkku Jäntti, Tommi Suvitaival, et al.
European Heart Journal. Cardiovascular Imaging|October 14, 2017
Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetesPeter Godsk Jørgensen, Tor Biering-Sørensen, Rasmus Mogelvang, et al.
Diabetes, Obesity & Metabolism|September 18, 2023
Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled studySuvanjaa Sivalingam, Victor Soendergaard Wasehuus, Viktor Rotbain Curovic, et al.
Ebiomedicine|May 9, 2022
Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetesNaba Al-Sari, Svetlana Kutuzova, Tommi Suvitaival, et al.
Journal of Negative Results in Biomedicine|May 10, 2011
The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetesAmélie Dendooven, Tri Q Nguyen, Lodewijk Brosens, et al.
BMJ (Clinical Research Ed.)|April 21, 2004
Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort studyPeter Hovind, Lise Tarnow, Peter Rossing, et al.
BMJ Open Diabetes Research & Care|July 5, 2022
Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuriaJanet B McGill, Hermann Haller, Prabir Roy-Chaudhury, et al.
Pageof 66